SCHEMBL12427136

SCHEMBL12427136

CNOC(=O)CC(c1ccccc1)c1cc(OC)cc2cc[nH]c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 2/20 0.41
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MGAM O43451 2/20 0.37
GAA P10253 2/20 0.37
SI P14410 2/20 0.37
MGAM2 Q2M2H8 2/20 0.37
CASR P41180 2/20 0.36
MTNR1A P48039 2/20 0.35
MTNR1B P49286 2/20 0.35
CACNA2D1 P54289 1/20 0.35
CACNA1B Q00975 1/20 0.35
CACNB1 Q02641 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PNP P00491 1/20 0.35
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2304044 0.87 TACR1 (0.47) TACR1MEN1KMT2AMGAMGAA
SCHEMBL2302810 0.86 TACR1 (0.41) TACR1MEN1KMT2AMGAMGAA
SCHEMBL13157420 0.82 CNR2 (0.35) TACR1MEN1KMT2AMGAMGAA
SCHEMBL2302540 0.79 SLC6A4 (0.53) MEN1KMT2AMTNR1AMTNR1BLMNA
SCHEMBL12427129 0.79 CTNNB1 (0.42) MEN1KMT2AMGAMGAASI
SCHEMBL12426748 0.71 KEAP1 (0.41) TACR1MEN1KMT2AMTNR1AMTNR1B
SCHEMBL2301585 0.70 PNP (0.41) TACR1PNPLMNAADRB1IKBKB
SCHEMBL2302365 0.69 TACR1 (0.44) TACR1MEN1KMT2ACACNA2D1CACNA1B
SCHEMBL2302650 0.69 MGAM (0.43) TACR1MEN1KMT2AMGAMGAA
SCHEMBL12427677 0.68 ROCK1 (0.39) L3MBTL1PNPLMNACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2351737-A1 3-Amino-1-arylpropyl indoles and aza-substituted indoles F. Hoffmann-La Roche AG (CH) 2011-08-03 EP disclosed
US-7803830-B2 3-amino-1-arylpropyl indoles and AZA-substituted indoles and uses thereof ROCHE PALO ALTO LLC (US) 2010-09-28 US disclosed
US-20090099236-A1 3-Amino-1-arylpropyl indoles and AZA-substituted indoles and uses thereof ROCHE PALO ALTO LLC 2009-04-16 US disclosed
US-7446118-B2 3-amino-1-arylpropyl indoles and aza-substituted indoles and uses thereof ROCHE PALO ALTO LLC (US) 2008-11-04 US disclosed
WO-2007062996-A1 3-AMINO-1-ARYLPROPYL INDOLES AND AZA-SUBSTITUTED INDOLES F. HOFFMANN-LA ROCHE AG (CH) 2007-06-07 WO disclosed
US-20070123527-A1 3-Amino-1-arylpropyl indoles and aza-substituted indoles and uses thereof ROCHE PALO ALTO LLC 2007-05-31 US disclosed
US-20070123527-A1 3-Amino-1-arylpropyl indoles and aza-substituted indoles and uses thereof ROCHE PALO ALTO LLC 2007-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070123527-A1 3-Amino-1-arylpropyl indoles and aza-substituted indoles and uses thereof IDO1, RB1, AHR TACR1 254/4885MEN1 2532/4885KMT2A 743/4885
US-20090099236-A1 3-Amino-1-arylpropyl indoles and AZA-substituted indoles and uses thereof IDO1, RB1, AHR TACR1 254/4885MEN1 2532/4885KMT2A 743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.